These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 15762320)

  • 1. Physicochemical characterization of protamine-phosphorothioate nanoparticles.
    Lochmann D; Vogel V; Weyermann J; Dinauer N; von Briesen H; Kreuter J; Schubert D; Zimmer A
    J Microencapsul; 2004 Sep; 21(6):625-41. PubMed ID: 15762320
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Albumin-protamine-oligonucleotide nanoparticles as a new antisense delivery system. Part 1: physicochemical characterization.
    Lochmann D; Weyermann J; Georgens C; Prassl R; Zimmer A
    Eur J Pharm Biopharm; 2005 Apr; 59(3):419-29. PubMed ID: 15760722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intracellular tracking of protamine/antisense oligonucleotide nanoparticles and their inhibitory effect on HIV-1 transactivation.
    Dinauer N; Lochmann D; Demirhan I; Bouazzaoui A; Zimmer A; Chandra A; Kreuter J; von Briesen H
    J Control Release; 2004 May; 96(3):497-507. PubMed ID: 15120905
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analysis of the complex formation of heparin with protamine by light scattering and analytical ultracentrifugation: implications for blood coagulation management.
    Maurer J; Haselbach S; Klein O; Baykut D; Vogel V; Mäntele W
    J Am Chem Soc; 2011 Feb; 133(4):1134-40. PubMed ID: 21186806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oligonucleotide-protamine-albumin nanoparticles: Protamine sulfate causes drastic size reduction.
    Mayer G; Vogel V; Weyermann J; Lochmann D; van den Broek JA; Tziatzios C; Haase W; Wouters D; Schubert US; Zimmer A; Kreuter J; Schubert D
    J Control Release; 2005 Aug; 106(1-2):181-7. PubMed ID: 16002173
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phosphodiester and phosphorothioate oligonucleotide condensation and preparation of antisense nanoparticles.
    Junghans M; Kreuter J; Zimmer A
    Biochim Biophys Acta; 2001 Jan; 1544(1-2):177-88. PubMed ID: 11341927
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing of a Secretoneurin Drug Delivery System with Self-Assembled Protamine Nanoparticles by Titration.
    Scheicher B; Lorenzer C; Gegenbauer K; Partlic J; Andreae F; Kirsch AH; Rosenkranz AR; Werzer O; Zimmer A
    PLoS One; 2016; 11(11):e0164149. PubMed ID: 27828968
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rationalizing nanomaterial sizes measured by atomic force microscopy, flow field-flow fractionation, and dynamic light scattering: sample preparation, polydispersity, and particle structure.
    Baalousha M; Lead JR
    Environ Sci Technol; 2012 Jun; 46(11):6134-42. PubMed ID: 22594655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ternary nanoparticles of anionic lipid nanoparticles/protamine/DNA for gene delivery.
    Yuan H; Zhang W; Du YZ; Hu FQ
    Int J Pharm; 2010 Jun; 392(1-2):224-31. PubMed ID: 20230883
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carbosilane dendrimers are a non-viral delivery system for antisense oligonucleotides: characterization of dendriplexes.
    Pedziwiatr-Werbicka E; Shcharbin D; Maly J; Maly M; Zaborski M; Gabara B; Ortega P; de la Mata FJ; Gómez R; Muñoz-Fernandez MA; Klajnert B; Bryszewska M
    J Biomed Nanotechnol; 2012 Feb; 8(1):57-73. PubMed ID: 22515094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of scanning electron microscopy, dynamic light scattering and analytical ultracentrifugation for the sizing of poly(butyl cyanoacrylate) nanoparticles.
    Bootz A; Vogel V; Schubert D; Kreuter J
    Eur J Pharm Biopharm; 2004 Mar; 57(2):369-75. PubMed ID: 15018998
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physicochemical characterisation of cationic polybutylcyanoacrylate-nanoparticles by fluorescence correlation spectroscopy.
    Weyermann J; Lochmann D; Georgens C; Rais I; Kreuter J; Karas M; Wolkenhauer M; Zimmer A
    Eur J Pharm Biopharm; 2004 Jul; 58(1):25-35. PubMed ID: 15207534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new drug nanocarrier consisting of polyarginine and hyaluronic acid.
    Oyarzun-Ampuero FA; Goycoolea FM; Torres D; Alonso MJ
    Eur J Pharm Biopharm; 2011 Sep; 79(1):54-7. PubMed ID: 21549838
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Formation mechanism of colloidal nanoparticles obtained from probucol/PVP/SDS ternary ground mixture.
    Pongpeerapat A; Wanawongthai C; Tozuka Y; Moribe K; Yamamoto K
    Int J Pharm; 2008 Mar; 352(1-2):309-16. PubMed ID: 18162340
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Graphene oxide stabilized by PLA-PEG copolymers for the controlled delivery of paclitaxel.
    Angelopoulou A; Voulgari E; Diamanti EK; Gournis D; Avgoustakis K
    Eur J Pharm Biopharm; 2015 Jun; 93():18-26. PubMed ID: 25817600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-assembled carrageenan/protamine polyelectrolyte nanoplexes-Investigation of critical parameters governing their formation and characteristics.
    Dul M; Paluch KJ; Kelly H; Healy AM; Sasse A; Tajber L
    Carbohydr Polym; 2015 Jun; 123():339-49. PubMed ID: 25843867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Preparation and characterization of low-molecular-weight heparin/protamine nanoparticles (LMW-H/P NPs) as FGF-2 carrier.
    Mori Y; Nakamura S; Kishimoto S; Kawakami M; Suzuki S; Matsui T; Ishihara M
    Int J Nanomedicine; 2010 Apr; 5():147-55. PubMed ID: 20463930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel method for measuring rigidity of submicron-size liposomes with atomic force microscopy.
    Nakano K; Tozuka Y; Yamamoto H; Kawashima Y; Takeuchi H
    Int J Pharm; 2008 May; 355(1-2):203-9. PubMed ID: 18280678
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antisense oligodeoxynucleotide-conjugated hyaluronic acid/protamine nanocomplexes for intracellular gene inhibition.
    Mok H; Park JW; Park TG
    Bioconjug Chem; 2007; 18(5):1483-9. PubMed ID: 17602578
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Depot formulation of vasoactive intestinal peptide by protamine-based biodegradable nanoparticles.
    Wernig K; Griesbacher M; Andreae F; Hajos F; Wagner J; Mosgoeller W; Zimmer A
    J Control Release; 2008 Sep; 130(2):192-8. PubMed ID: 18601963
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.